相关实验视频

Updated: Jul 1, 2025

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

对N1303K变异的CFTR调节器治疗效率的综合评估

Anna Efremova¹, Nataliya Kashirskaya^1,2, Stanislav Krasovskiy^1,3

¹Research Centre for Medical Genetics, Moscow 115522, Russia.

International journal of molecular sciences

|March 13, 2024

概括

埃莱克萨卡夫托,特萨卡夫托和伊瓦卡夫托 (ETI) 在患有N1303K变异的患者中有效地恢复囊性纤维化转膜导电性调节器 (CFTR) 功能. 这种组合疗法显示出显著的临床益处,改善肺功能和整体健康.

科学领域:

遗传学和分子生物学
医学遗传学医学遗传学
药理学药理学是指药理学的学科.

背景情况:

囊性纤维化 (CF) 是由CFTR基因的突变引起的.
该p.Asn1303Lys (N1303K) 变异是一种常见的误解突变,导致CF.
CFTR调节器为CF患者提供了潜在的治疗策略.

研究的目的:

评估CFTR调节器在恢复N1303K-CFTR功能的有效性.
评估Elexacaftor + Tezacaftor + Ivacaftor (ETI) 对N1303K-CFTR变种的影响.
为了研究ETI治疗在患有N1303K/I类基因型的患者的临床有效性.

主要方法:

来自CF患者肠道组织的器官培养.
福斯科林诱导的胀试验测量CFTR功能.
肠道流量测量 (ICM) 和治疗前后的临床评估.

主要成果:

在患者衍生器官中,ETI显著改善了N1303K-CFTR功能.
ICM证实在三个月的ETI治疗后,肠上皮质恢复了CFTR功能.
患者表现出改善的临床状态,肺功能,BMI,并减少了致病性肺菌群的多样性.

结论:

对于恢复N1303K-CFTR功能,ETI是一种有效的治疗选择.
在患有N1303K变异的患者中,ETI显示出显著的临床益处.
虽然汗水测试结果没有改善,但整体临床结果表明ETI的疗效.

关键词:

这就是为什么BMI是BMI.在 FEV1 中,FEV1 是 FEV1.N1303K 没有没有临床状态临床状态囊性纤维化症是什么肠道电流测量肠道电流测量肠道有机体是什么意思

更多相关视频

Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine

Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine

Published on: April 22, 2022

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein

Published on: March 9, 2015

相关概念视频

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...

GPCRs Regulate Adenylyl Cylase Activity

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...